Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Validation of the Royal Marsden hospital prognostic index in advanced esophagogastric cancer using individual patient data from the REAL 2 study.

× No keyword cloud information.

20 in total

1. A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and Chemotherapy.

Authors: Dongwoo Chae; Chung Mo Nam; Joo Hoon Kim; Choong-Kun Lee; Seung-Seob Kim; Hyo Song Kim; Minkyu Jung; Jae Ho Cheong; Hyun Cheol Chung; Sun Young Rha; Kyungsoo Park
Journal: AAPS J Date: 2018-05-29 Impact factor: 4.009

2. Systemic chemotherapy as a main strategy for liver metastases from gastric cancer.

Authors: W Zhang; Y Yu; Y Fang; Y Wang; Y Cui; K Shen; T Liu
Journal: Clin Transl Oncol Date: 2015-06-25 Impact factor: 3.405

3. Clinical effectiveness and toxicity of second-line irinotecan in advanced gastric and gastroesophageal junction adenocarcinoma: a single-center observational study.

Authors: Sebastian Ochenduszko; Mirosława Puskulluoglu; Kamil Konopka; Kamil Fijorek; Agnieszka Julia Slowik; Michał Pędziwiatr; Andrzej Budzyński
Journal: Ther Adv Med Oncol Date: 2017-02-07 Impact factor: 8.168

4. Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy.

Authors: Iain Beehuat Tan; Tatiana Ivanova; Kiat Hon Lim; Chee Wee Ong; Niantao Deng; Julian Lee; Sze Huey Tan; Jeanie Wu; Ming Hui Lee; Chia Huey Ooi; Sun Young Rha; Wai Keong Wong; Alex Boussioutas; Khay Guan Yeoh; Jimmy So; Wei Peng Yong; Akira Tsuburaya; Heike Grabsch; Han Chong Toh; Steven Rozen; Jae Ho Cheong; Sung Hoon Noh; Wei Kiat Wan; Jaffer A Ajani; Ju-Seog Lee; Manuel Salto Tellez; Patrick Tan
Journal: Gastroenterology Date: 2011-04-28 Impact factor: 22.682

Review 5. Biomarkers for gastric cancer: prognostic, predictive or targets of therapy?

Authors: Cecília Durães; Gabriela M Almeida; Raquel Seruca; Carla Oliveira; Fátima Carneiro
Journal: Virchows Arch Date: 2014-02-01 Impact factor: 4.064

6. Sequential chemotherapy with cisplatin, leucovorin, and 5-fluorouracil followed by docetaxel in previously untreated patients with metastatic gastric cancer: a phase II study.

Authors: Vincenzo Catalano; Bruno Vincenzi; Paolo Giordani; Francesco Graziano; Daniele Santini; Anna Maria Baldelli; Paolo Alessandroni; Gaia Schiavon; David Rossi; Virginia Casadei; Silvia D'Emidio; Stefano Luzi Fedeli; Giuseppe Tonini; Giammaria Fiorentini
Journal: Gastric Cancer Date: 2012-01-12 Impact factor: 7.370

Review 7. Reporting patient characteristics and stratification factors in randomized trials of systemic chemotherapy for advanced gastric cancer.

Authors: Kohei Shitara; Junko Ikeda; Chihiro Kondo; Daisuke Takahari; Takashi Ura; Kei Muro; Keitaro Matsuo
Journal: Gastric Cancer Date: 2011-08-13 Impact factor: 7.370

8. Validation of the JCOG prognostic index in advanced gastric cancer using individual patient data from the SPIRITS and G-SOX trials.

Authors: Daisuke Takahari; Junki Mizusawa; Wasaburo Koizumi; Ichinosuke Hyodo; Narikazu Boku
Journal: Gastric Cancer Date: 2017-02-16 Impact factor: 7.370

9. A phase II study of modified FOLFOX as first-line chemotherapy for metastatic gastric cancer in elderly patients with associated diseases.

Authors: Vincenzo Catalano; Renato Bisonni; Francesco Graziano; Paolo Giordani; Paolo Alessandroni; Anna Maria Baldelli; Virginia Casadei; David Rossi; Stefano Luzi Fedeli; Silvia D'Emidio; Lucio Giustini; Giammaria Fiorentini
Journal: Gastric Cancer Date: 2012-10-11 Impact factor: 7.370

10. Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial.

Authors: N C Tebbutt; M M Cummins; T Sourjina; A Strickland; G Van Hazel; V Ganju; D Gibbs; M Stockler; V Gebski; J Zalcberg
Journal: Br J Cancer Date: 2010-01-12 Impact factor: 7.640